Ketamine Not Yet Recruiting Phase 4 Trials for Treatment Resistant Depression (TRD) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02772211D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression